XYD198 (Compound 14h) is an orally active degrader of CBP/p300. It inhibits the CBP/p300 bromodomain with an IC50 of 213.5 nM and exhibits antitumor activity against acute myeloid leukemia.
Formula:
C54H49F2N11O7
Target:
PROTACs,Epigenetic Reader Domain
* VAT and and shipping costs not included. Errors and price changes excepted
